Swanson C et al. |
FK 506-based immunosuppression in clinical pancreas transplantation. |
1995 |
Transplant. Proc. |
pmid:8539827
|
Tesi RJ et al. |
Conversion of pancreas transplants to FK 506 from CsA. |
1995 |
Transplant. Proc. |
pmid:8539828
|
Burke GW et al. |
Use of FK 506 in simultaneous pancreas/kidney transplantation: lack of impairment of glycemic or lipid metabolism. |
1995 |
Transplant. Proc. |
pmid:8539872
|
Burke GW et al. |
The use of FK506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression. |
1995 |
Transplant. Proc. |
pmid:8539874
|
Klintmalm GB and Gonwa TA |
Nephrotoxicity associated with cyclosporine and FK506. |
1995 |
Liver Transpl Surg |
pmid:9346596
|
Gruessner RW et al. |
A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation. |
1995 |
Transplantation |
pmid:7530871
|
Wong PY et al. |
FK506 in liver transplantation for chronic hepatitis B: in vitro studies on lymphocyte activation and virus replication. |
1995 |
Liver Transpl Surg |
pmid:9346613
|
Todo S et al. |
Abdominal multivisceral transplantation. |
1995 |
Transplantation |
pmid:7530873
|
Monfar M et al. |
Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP. |
1995 |
Mol. Cell. Biol. |
pmid:7528328
|
Fukuzaki T et al. |
A protocol with FK 506 for inducing unresponsiveness to murine islet allografts. |
1995 |
Surgery |
pmid:7531371
|
Cox KL et al. |
An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. |
1995 |
Transplantation |
pmid:7533344
|
McDiarmid SV et al. |
FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. |
1995 |
Transplantation |
pmid:7533345
|
Jain AB et al. |
One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events. |
1995 |
Transplant. Proc. |
pmid:7533353
|
Rucay P et al. |
FK 506 as treatment of late acute rejection in liver transplant patients. |
1995 |
Transplant. Proc. |
pmid:7533354
|
Schwartz M et al. |
FK 506 in liver transplantation: correlation of whole blood levels with efficacy and toxicity. The US Multicenter FK 506 Dose Optimization. |
1995 |
Transplant. Proc. |
pmid:7533355
|
Yasuhara M et al. |
Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations. |
1995 |
Transplant. Proc. |
pmid:7533356
|
Platz KP et al. |
OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection. |
1995 |
Transplant. Proc. |
pmid:7533357
|
Bierer BE |
Mechanisms of action of immunosuppressive agents: cyclosporin A, FK506, and rapamycin. |
1995 |
Proc. Assoc. Am. Physicians |
pmid:8630742
|
Porayko MK et al. |
Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group. |
1995 |
Transplant. Proc. |
pmid:7533358
|
Chakraborty TK et al. |
Design and synthesis of a rapamycin-based high affinity binding FKBP12 ligand. |
1995 |
Chem. Biol. |
pmid:9383417
|
Celli S et al. |
Mechanisms of protection from humoral rejection by a xenografted liver. |
1995 |
Transplant. Proc. |
pmid:7533395
|
Kuroki H and Ikuta Y |
Nerve regeneration of vascularized rat limb allograft and functional recovery of long-term graft survivals treated by short course of FK 506 or cyclosporine. |
1995 |
Transplant. Proc. |
pmid:7533405
|
Ko S et al. |
Significance of newly developed liposomal FK 506 in canine liver transplantation. |
1995 |
Transplant. Proc. |
pmid:7533406
|
Fukuzaki T et al. |
Induction of unresponsiveness to islet allografts with donor spleen cell inoculation followed by a single injection of FK 506. |
1995 |
Transplant. Proc. |
pmid:7533407
|
Grochowicz PM et al. |
Synergism of castanospermine and FK 506. |
1995 |
Transplant. Proc. |
pmid:7533408
|
Itoh S and Navia MA |
Structure comparison of native and mutant human recombinant FKBP12 complexes with the immunosuppressant drug FK506 (tacrolimus). |
1995 |
Protein Sci. |
pmid:8563622
|
Tamura K et al. |
Inhibition of insulin production by FK 506 is caused at the transcriptional level in pancreatic beta cell when FK BP-12 content is relatively high. |
1995 |
Transplant. Proc. |
pmid:7533409
|
Kawano K et al. |
Protective effect of FK 506 on hepatic injury following cold ischemic preservation and transplantation: influence on hepatic microcirculation. |
1995 |
Transplant. Proc. |
pmid:7533410
|
Charters AR et al. |
Developmental expression of FK506 binding proteins and calcineurin in rat brain. |
1995 |
Biochem. Soc. Trans. |
pmid:8566310
|
Tanabe M et al. |
Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation. |
1995 |
Transplant. Proc. |
pmid:7533411
|
Abu-Elmagd K et al. |
The current status of hepatic transplantation at the University of Pittsburgh. |
1995 |
Clin Transpl |
pmid:8794262
|
Masri MA |
Comparative study of toxicity and efficacy of cyclosporine, cyclosporine G (OG37), FK 506, and rapamycin in BALB/c mice with fitted skin grafts. |
1995 |
Transplant. Proc. |
pmid:7533412
|
Shapiro R et al. |
The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience. |
1995 |
Clin Transpl |
pmid:8794266
|
Swenson JM et al. |
Immunosuppression switch in pediatric heart transplant recipients: cyclosporine to FK 506. |
1995 |
J. Am. Coll. Cardiol. |
pmid:7534779
|
Sen J et al. |
Expression and induction of nuclear factor-kappa B-related proteins in thymocytes. |
1995 |
J. Immunol. |
pmid:7534792
|
Hodgkiss JP and Kelly JS |
Only 'de novo' long-term depression (LTD) in the rat hippocampus in vitro is blocked by the same low concentration of FK506 that blocks LTD in the visual cortex. |
1995 |
Brain Res. |
pmid:8821755
|
Komori T |
[The change of lymphocyte subset and effect of FK506 in experimental small bowel transplantation of rats]. |
1995 |
Nihon Geka Gakkai Zasshi |
pmid:7534867
|
Woo J et al. |
Combined effects of FK506 (tacrolimus) and cyclophosphamide on atypical B220+ T cells, cytokine gene expression and disease activity in MRL/MpJ-lpr/lpr mice. |
1995 |
Clin. Exp. Immunol. |
pmid:7535208
|
Jusko WJ et al. |
Pharmacokinetics of tacrolimus in liver transplant patients. |
1995 |
Clin. Pharmacol. Ther. |
pmid:7535213
|
Furuke K et al. |
Suppression of adult T cell leukemia-derived factor/human thioredoxin induction by FK506 and cyclosporin A: a new mechanism of immune modulation via redox control. |
1995 |
Int. Immunol. |
pmid:7577807
|
Ockenfels HM et al. |
Cyclosporin A, FK506 and dithranol after tyrosine-specific protein phosphorylation in HaCaT keratinocytes. |
1995 |
Arch. Dermatol. Res. |
pmid:7541191
|
Victor RG et al. |
Presynaptic modulation of cortical synaptic activity by calcineurin. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7541535
|
Mehta BA et al. |
Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells. |
1995 |
Blood |
pmid:7579455
|
Kaufman DB et al. |
The successful use of tacrolimus (FK506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome. |
1995 |
Transplantation |
pmid:7541579
|
Coss MC et al. |
Molecular cloning, DNA sequence analysis, and biochemical characterization of a novel 65-kDa FK506-binding protein (FKBP65). |
1995 |
J. Biol. Chem. |
pmid:7493967
|
Hemenway C |
FK506 in bone marrow transplantation. |
1995 |
Blood |
pmid:7579473
|
McDiarmid SV et al. |
The treatment of intractable rejection with tacrolimus (FK506) in pediatric liver transplant recipients. |
1995 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:7541834
|
Büttemeyer R et al. |
Peripheral nerve allotransplant immunosuppressed with FK 506: preliminary results. |
1995 |
Transplant. Proc. |
pmid:7536979
|
Lee MJ et al. |
Physicochemical, pharmacokinetic and pharmacodynamic evaluation of liposomal tacrolimus (FK 506) in rats. |
1995 |
Pharm. Res. |
pmid:7494802
|
Yamamoto M et al. |
Cyclosporin A and FK506 reverse anthracycline resistance by altering the cell cycle. |
1995 |
Anticancer Drugs |
pmid:7579561
|
Arita S et al. |
Effect of FK 506 in experimental pancreas transplantation. |
1995 |
Transplant. Proc. |
pmid:7536980
|
Zhao Y and Iwata M |
Cross-linking of the TCR-CD3 complex with CD4, CD8 or LFA-1 induces an anti-apoptotic signal in thymocytes: the signal is canceled by FK506. |
1995 |
Int. Immunol. |
pmid:7495746
|
O'Gorman MA et al. |
Proximal renal tubular acidosis secondary to FK506 in pediatric liver transplant patients. |
1995 |
Clin Transplant |
pmid:7579739
|
Aono T et al. |
Minimal threshold of FK 506 for enhancing liver regeneration in thymectomized rats. |
1995 |
Transplant. Proc. |
pmid:7536981
|
Saito T et al. |
In situ dephosphorylation of tau by protein phosphatase 2A and 2B in fetal rat primary cultured neurons. |
1995 |
FEBS Lett. |
pmid:7498550
|
Kanamaru A et al. |
FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group. |
1995 |
Bone Marrow Transplant. |
pmid:7581086
|
Iwabuchi T et al. |
Effects of immunosuppressive peptidyl-prolyl cis-trans isomerase (PPIase) inhibitors, cyclosporin A, FK506, ascomycin and rapamycin, on hair growth initiation in mouse: immunosuppression is not required for new hair growth. |
1995 |
J. Dermatol. Sci. |
pmid:7537082
|
Antoni FA et al. |
Calcineurin feedback inhibition of agonist-evoked cAMP formation. |
1995 |
J. Biol. Chem. |
pmid:7499291
|
Koehler MT et al. |
FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation. |
1995 |
Bone Marrow Transplant. |
pmid:7581088
|
Arnold JC and Theilmann L |
[Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation]. |
1995 |
Z Gastroenterol |
pmid:7502559
|
Reisman L et al. |
Modulation of interleukin-1 secretion by immunosuppressive drugs, alone and in combination. |
1995 |
Transpl. Immunol. |
pmid:7551978
|
Osman A et al. |
Schistosoma mansoni: characterization of p50, an immunophilin. |
1995 |
Exp. Parasitol. |
pmid:7537219
|
Tanida I et al. |
Cooperation of calcineurin and vacuolar H(+)-ATPase in intracellular Ca2+ homeostasis of yeast cells. |
1995 |
J. Biol. Chem. |
pmid:7537264
|
Koch K et al. |
The C-32 triacetyl-L-rhamnose derivative of ascomycin: a potent, orally active macrolactone immunosuppressant. |
1995 |
J. Med. Chem. |
pmid:7537331
|
Griffith JP et al. |
X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. |
1995 |
Cell |
pmid:7543369
|
Prud'homme GJ et al. |
Effects of cyclosporin A, rapamycin, and FK520 on peripheral T-cell deletion and anergy. |
1995 |
Cell. Immunol. |
pmid:7543371
|
Migita K et al. |
FK506 augments activation-induced programmed cell death of T lymphocytes in vivo. |
1995 |
J. Clin. Invest. |
pmid:7543492
|
Lhoëst G et al. |
The in vitro immunosuppressive activity of the C15-demethylated metabolite of FK-506 is governed by ring- and open-chain tautomerism effects. |
1995 |
J. Pharmacol. Exp. Ther. |
pmid:7543569
|
Schleibner S et al. |
FK 506 versus cyclosporin in the prevention of renal allograft rejection--European pilot study: six-week results. |
1995 |
Transpl. Int. |
pmid:7539270
|
Textor SC et al. |
Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation. |
1995 |
Kidney Int. |
pmid:7543625
|
Ko S et al. |
The enhanced immunosuppressive efficacy of newly developed liposomal FK506 in canine liver transplantation. |
1995 |
Transplantation |
pmid:7539553
|
Dollinger MM et al. |
Tacrolimus and cardiotoxicity in adult liver transplant recipients. |
1995 |
Lancet |
pmid:7543645
|
Fealy MJ et al. |
Association of down-regulation of cytokine activity with rat hind limb allograft survival. |
1995 |
Transplantation |
pmid:7539555
|
Romero DF et al. |
Rapamycin: a bone sparing immunosuppressant? |
1995 |
J. Bone Miner. Res. |
pmid:7543725
|
Rebollo A et al. |
Differential effect of rapamycin and cyclosporin A in proliferation in a murine T cell line expressing either intermediate or high affinity receptor for IL-2. |
1995 |
Cytokine |
pmid:7543780
|
Hisatomi K et al. |
Changes in the mononuclear cell subpopulations of rat cardiac transplant recipients administered FK506 for the treatment of ongoing rejection. |
1995 |
Surg. Today |
pmid:7539647
|
Tamura K et al. |
Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. |
1995 |
Transplantation |
pmid:7539960
|
Fisher A et al. |
FK506 hepatotoxicity in liver allograft recipients. |
1995 |
Transplantation |
pmid:7539961
|
Monsour HP et al. |
Renal insufficiency and hypertension as long-term complications in liver transplantation. |
1995 |
Semin. Liver Dis. |
pmid:7544917
|
Varela E |
[Small bowel transplantation]. |
1995 |
Acta Gastroenterol. Latinoam. |
pmid:7544939
|
Taler SJ et al. |
Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy. |
1995 |
Am. J. Hypertens. |
pmid:7544983
|
Starzl TE et al. |
Randomised trialomania? The multicentre liver transplant trials of tacrolimus. |
1995 |
Lancet |
pmid:7475777
|
Teague S |
Lessons from molecular matchmakers. |
1995 |
Nat. Struct. Biol. |
pmid:7545076
|
Milad M et al. |
Interaction of the progesterone receptor with binding proteins for FK506 and cyclosporin A. |
1995 |
Mol. Endocrinol. |
pmid:7476967
|
Ito T et al. |
Immunosuppressive agents induce the reduction of local pancreatic blood flow. |
1995 |
Pancreas |
pmid:7545292
|
Zhang J and Steiner JP |
Nitric oxide synthase, immunophilins and poly(ADP-ribose) synthetase: novel targets for the development of neuroprotective drugs. |
1995 |
Neurol. Res. |
pmid:7477744
|
Han CW et al. |
Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression. |
1995 |
Bone Marrow Transplant. |
pmid:7545487
|
Jindal RM and Popescu I |
Renal dysfunction associated with liver transplantation. |
1995 |
Postgrad Med J |
pmid:7479462
|
Hattori Y and Nakanishi N |
Effects of cyclosporin A and FK506 on nitric oxide and tetrahydrobiopterin synthesis in bacterial lipopolysaccharide-treated J774 macrophages. |
1995 |
Cell. Immunol. |
pmid:7545550
|
Yeh WC et al. |
Identification and characterization of an immunophilin expressed during the clonal expansion phase of adipocyte differentiation. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7479941
|
Yeh WC et al. |
Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7479942
|
Shaw KT et al. |
Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7479966
|
Annesley TM et al. |
Stability of tacrolimus (FK 506) and cyclosporin G in whole blood. |
1995 |
Ther Drug Monit |
pmid:7482690
|
Holsinger LJ et al. |
Signal transduction in T lymphocytes using a conditional allele of Sos. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7568223
|
Faerman CH and Karplus PA |
Consensus preferred hydration sites in six FKBP12-drug complexes. |
1995 |
Proteins |
pmid:8539241
|
Groth CG |
Immunosuppressive regimens of tomorrow. |
1995 |
Transplant. Proc. |
pmid:8539797
|
Sekigawa I et al. |
Inhibitory effect of the immunosuppressant FK506 on apoptotic cell death induced by HIV-1 gp120. |
1995 |
J. Clin. Immunol. |
pmid:8576317
|
Hariharan S et al. |
Conversion from cyclosporine to tacrolimus after pancreas transplantation. |
1995 |
Transplant. Proc. |
pmid:8539799
|
Henley SE et al. |
Lipids following pancreas transplantation in recipients receiving FK 506. |
1995 |
Transplant. Proc. |
pmid:8539809
|
Stratta RJ et al. |
Preliminary experience with FK 506 in pancreas transplant recipients. |
1995 |
Transplant. Proc. |
pmid:8539823
|